Will You Need Lifelong Treatment and Can You Ever Drink Again?
Yes, you will most likely need lifelong immunosuppressive therapy for your chronic autoimmune disease, and while you cannot drink freely, modest occasional alcohol consumption may be acceptable if you have no other liver risk factors and maintain close monitoring. 1
Duration of Immunosuppressive Therapy
The reality is stark but important to understand: due to the chronic nature of autoimmune diseases like autoimmune hepatitis (AIH), the majority of patients require long-term, often lifelong, immunosuppressive therapy. 1 This is because:
- The disease arises in genetically susceptible individuals, making the disease risk lifelong
- Most patients have already experienced a subclinical chronic course before diagnosis
- Even acute presentations evolve into chronic disease requiring sustained treatment
- The risk of relapse remains high, potentially occurring many years or even decades after treatment cessation 1
When Treatment Cessation Might Be Considered
A trial of stopping treatment should only be attempted if ALL of the following criteria are met:
- You've maintained stable complete biochemical response (CBR) on low-dose monotherapy for at least 2 years
- Disease activity assessment (aminotransferases, IgG, and/or liver biopsy) shows no residual activity
- You don't have reactivity to SLA/LP autoantigen (which typically requires permanent immunosuppression)
- After first relapse following withdrawal, subsequent attempts are not recommended 1
Critical caveat: If you do attempt withdrawal, monitoring must occur at least every 3 months in the first year, then adapted individually, as relapses can occur many years later. 1
Alcohol Consumption While on Methotrexate and Prednisone
The Official Position
Methotrexate FDA labeling lists "excessive alcohol intake" as a relative contraindication, and patients with alcoholism or alcoholic liver disease should not receive methotrexate. 2 The British dermatology guidelines state there is no evidence for a "safe" level of alcohol while on methotrexate, recommending patients limit intake to "well below national guidelines." 3
The Practical Reality
However, a pragmatic discussion around occasional consumption of modest volumes of alcohol is reasonable, especially if you have no other hepatic risk factors (no diabetes, obesity, or pre-existing liver disease). 3
Research evidence supports this nuanced approach:
- Weekly alcohol consumption of <14 units per week does not appear associated with increased risk of transaminitis (liver enzyme elevation) 4
- Consuming 15-21 units weekly shows possible increased risk
- Drinking >21 units per week significantly increases rates of transaminitis (adjusted HR 1.85) 4
What This Means for You
You should:
- Limit alcohol to well below 14 units per week (approximately 6-7 standard drinks)
- Avoid regular daily drinking
- Maintain regular blood monitoring for liver function
- Understand that diabetes and obesity increase hepatic risk 3
- Accept that complete abstinence is the safest approach, but occasional modest consumption with close monitoring is a reasonable compromise 3, 4
Common Pitfalls to Avoid
Don't assume you can stop treatment once you feel better - this leads to relapse in the majority of patients 1
Don't underestimate cumulative alcohol exposure - even "moderate" drinking over years can cause problems when combined with methotrexate 3
Don't skip monitoring - liver toxicity from methotrexate can occur without symptoms, and regular blood tests are essential 2
Don't attempt treatment withdrawal without medical supervision - immunosuppression must be reduced stepwise, as flares during dose reduction are frequent 1
The bottom line: This is likely a lifelong journey with your medications, but with proper monitoring, occasional modest alcohol consumption may be possible - though complete abstinence remains the safest choice. 1, 3, 4